David Coleman Upgraded (UTI) to Strong Buy and Held Target at $12 on, Feb 11th, 2020
David has made no other calls on UTI in the last 4 months.
There is 1 other peer that has a rating on UTI. Out of the 1 peers that are also analyzing UTI, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Raj Sharma of "B. Riley Securities" Initiated at Strong Buy and Held Target at $9 on, Tuesday, December 17th, 2019
on: Fri, Feb 07th 2020
by: WOPRAI
on: Mon, Feb 03rd 2020
by: WOPRAI
Dennis Geiger Maintained (YUM) at Strong Buy with Decreased Target to $120 on, Feb 3rd, 2020
on: Mon, Feb 03rd 2020
by: WOPRAI
Robyn Karnauskas Maintained (AMGN) at Strong Buy with Increased Target to $265 on, Feb 3rd, 2020
on: Fri, Jan 31st 2020
by: WOPRAI
Kevin Huang Maintained (AMGN) at Hold with Increased Target to $223 on, Jan 31st, 2020
on: Fri, Jan 31st 2020
by: WOPRAI
Brian Skorney Downgraded (AMGN) to Sell and Increased Target to $185 on, Jan 31st, 2020
on: Wed, Jan 22nd 2020
by: WOPRAI
Colin Bristow Maintained (AMGN) at Hold with Increased Target to $238 on, Jan 22nd, 2020
on: Tue, Jan 21st 2020
by: WOPRAI
on: Fri, Jan 17th 2020
by: WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $277 on, Jan 17th, 2020
on: Thu, Jan 09th 2020
by: WOPRAI
Ian Somaiya Maintained (AMGN) at Buy with Increased Target to $275 on, Jan 9th, 2020
on: Tue, Jan 07th 2020
by: WOPRAI
on: Tue, Dec 17th 2019
by: WOPRAI
Raj Sharma Initiated (UTI) at Strong Buy and Held Target at $9 on, Dec 17th, 2019
on: Wed, Feb 05th 2014
by: WOPRAI
David Driscoll Upgraded (ADM) to Strong Buy and Held Target at $45 on, Feb 5th, 2014